Polypharmacy in Parkinson’s disease: risks and benefits with little evidence
Crossref DOI link: https://doi.org/10.1007/s00702-019-02026-8
Published Online: 2019-06-20
Published Print: 2019-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Csoti, I.
Herbst, H.
Urban, P.
Woitalla, D.
Wüllner, U. http://orcid.org/0000-0002-3132-0790
Text and Data Mining valid from 2019-06-20
Version of Record valid from 2019-06-20
Article History
Received: 3 April 2019
Accepted: 1 June 2019
First Online: 20 June 2019